Editor's Note The Centers for Disease Control and Prevention (CDC), on April 28, reported that more than 98 million people in the US are fully vaccinated against COVID-19, which is 29.5% of the population. The count included two-dose vaccines from Moderna and Pfizer/BioNTech, as well as the Janssen/Johnson & Johnson’s…
Editor's Note In this study, researchers from the Centers for Disease Control and Prevention (CDC) found that COVID-19 vaccines developed by Pfizer-BioNTech and Moderna were 94% effective in preventing hospitalizations in US adults aged 65 and older who were fully vaccinated. The vaccines were 64% effective at preventing hospitalization in…
Editor's Note The Joint Commission, on April 28, announced that it has developed a new COVID-19 vaccine resources page to help consumers make a more informed decision about getting vaccinated. The page provides insights from experts about the vaccines, resources from the Centers for Disease Control and Prevention, and sample…
Editor's Note This study by researchers from the Centers for Disease Control and Prevention (CDC) finds that, based on a data-driven model, keeping middle seats in aircraft cabins vacant could reduce exposure to COVID-19. Compared with full aircraft occupancy, exposures to viable virus particles in scenarios when middle seats were…
Editor's Note The Centers for Disease Control and Prevention (CDC), on April 27, announced new interim public health recommendations on activities fully vaccinated people can resume with and without wearing a mask. Among the recommendations: Fully vaccinated people can attend small gatherings outdoors with other vaccinated people or a mix…
Editor's Note This study from Israel finds that children aged 0 to 9 years did not have substantial rates of COVID-19 infection during school attendance periods, and they did not have a substantial role in COVID-19 spread. Researchers analyzed data from 47,620 children aged 0 to 9 years; 101,304 youths…
Editor's Note The Food and Drug Administration (FDA), on April 26, identified the recall by Cordis Corporation of its Precise PRO Rx US Carotid System as Class I, the most serious. The Carotid System is being recalled due to a risk of separation of the atraumatic distal tip of the…
Editor's Note This study by researchers at the Massachusetts Institute of Technology, Cambridge, finds that the transmission risk of COVID-19 is reduced in large rooms with high air exchange rates, increased with vigorous respiratory activities, and reduced with face masks. The researchers developed a method of calculating exposure risk to…
Editor's Note The US Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), on April 23, announced that after a thorough safety review, the pause on the Janssen/Johnson & Johnson (J&J) COVID-19 vaccine should be lifted, and use of the vaccine should resume. The pause was…
Editor's Note The Food and Drug Administration (FDA), on April 20, identified the recall of Medtronic’s Bio-Console 560 Extracorporeal Blood Pumping Console as Class I, the most serious. The Console is used during heart surgery to pump and return blood to a patient during cardiopulmonary bypass. The recall was initiated…